Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) EBITDA (2024 - 2025)

RenovoRx's EBITDA history spans 2 years, with the latest figure at -$3.2 million for Q3 2025.

  • For Q3 2025, EBITDA fell 13.15% year-over-year to -$3.2 million; the TTM value through Sep 2025 reached -$11.6 million, changed N/A, while the annual FY2024 figure was -$8.8 million, 13.86% up from the prior year.
  • EBITDA for Q3 2025 was -$3.2 million at RenovoRx, down from -$2.7 million in the prior quarter.
  • Across five years, EBITDA topped out at -$2.5 million in Q1 2024 and bottomed at -$3.2 million in Q3 2025.